about
Feline leukemia virus long terminal repeat activates collagenase IV gene expression through AP-1High expression of tumor-associated antigen RCAS1 in pancreatic ductal adenocarcinoma is an unfavorable prognostic marker.Exogenous expression of mouse interferon gamma cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented anti-tumor immunityCo-culture of primary human tumor hepatocytes from patients with hepatocellular carcinoma with autologous peripheral blood mononuclear cells: study of their in vitro immunological interactions.Expression of class I and class II major histocompatibility antigens on human hepatocellular carcinomaReduced tumorigenicity of a spontaneous mouse lung carcinoma following H-2 gene transfection.HLA-DR and beta 2 microglobulin expression in medullary and atypical medullary carcinoma of the breast: histopathologically similar but biologically distinct entities.Mitotic recombination in germ cells generated two major histocompatibility complex mutant genes shown to be identical by RNA sequence analysis: Kbm9 and Kbm6.Identification of a cis-acting element in the class I major histocompatibility complex gene promoter responsive to activation by retroviral sequences.Changes in NF-kappa B and ISGF3 DNA binding activities are responsible for differences in MHC and beta-IFN gene expression in Ad5- versus Ad12-transformed cells.Immunogenic capacity of tum--variants isolated from a rat rhabdomyosarcomaA trans-acting mechanism represses the expression of the major transplantation antigens in mouse hybrid thymoma cell lines.Structure and function of three novel MHC class I antigens derived from a C3H ultraviolet-induced fibrosarcoma.Suppression of class I human histocompatibility leukocyte antigen by c-myc is locus specificDownregulation of peptide transporter genes in cell lines transformed with the highly oncogenic adenovirus 12.LMP-associated proteolytic activities and TAP-dependent peptide transport for class 1 MHC molecules are suppressed in cell lines transformed by the highly oncogenic adenovirus 12.HLA expression in human hepatocellular carcinomaInstability of expression of major histocompatibility antigens in fibroblasts expressing activated ras oncogene: constitutive and interferon-gamma induced class I and class II antigens in a series of clonal isolates of murine fibroblasts transformedConcurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinoma.Driving adenovirus type 12-transformed BALB/c mouse cells to express high levels of class I major histocompatibility complex proteins enhances, rather than abrogates, their tumorigenicityAutocrine induction of major histocompatibility complex class I antigen expression results from induction of beta interferon in oncogene-transformed BALB/c-3T3 cellsBinding of a nuclear factor to a regulatory sequence in the promoter of the mouse H-2Kb class I major histocompatibility geneMurine retroviruses control class I major histocompatibility antigen gene expression via a trans effect at the transcriptional level.Negative and positive regulation of human leukocyte antigen class I gene transcription in K562 leukemia cells.Inhibition of HLA class I antigen and mRNA expression induced by Rous sarcoma virus in transformed human fibroblasts.A transcription factor interacting with the class I gene enhancer is inactive in tumorigenic cell lines which suppress major histocompatibility complex class I genes.Inverse correlation of HER2 with MHC class I expression on oesophageal squamous cell carcinoma.Transcriptional and posttranscriptional regulation of class I major histocompatibility complex genes following transformation with human adenoviruses.A phase I trial of immunotherapy with intratumoral adenovirus-interferon-gamma (TG1041) in patients with malignant melanoma.A novel downstream regulatory element of the mouse H-2Kb class I major histocompatibility geneInducibility of class II major histocompatibility complex antigens by interferon gamma is associated with reduced tumorigenicity in C3H mouse fibroblasts transformed by v-Ki-ras.Tumour surveillance: missing peptides and MHC molecules.Phosphorylation of class I histocompatibility antigens in human B lymphocytes. Regulation by phorbol esters and insulin.Down-regulation of the MHC class I antigen-processing machinery after oncogenic transformation of murine fibroblasts.Cellular B-2 microglobulin expression as a prognostic indicator in renal cell carcinoma.MHC class I heavy chain mRNA must exceed a threshold level for the reconstitution of cell surface expression of class I MHC complexes in cells transformed by the highly oncogenic adenovirus 12.
P2860
Q33814106-FA74C005-3E7F-4519-83EA-8A809492312FQ34126942-C2B41E91-B47E-4E85-B39E-726C0C715A5DQ34323590-DD065329-E74C-4E01-A78B-FFF74167630FQ34554049-1259E743-B91E-489C-8115-DBD5F21713E5Q34565727-17E67C50-3AB1-4531-BD1B-2C88B50281A7Q34635843-6C5CDA15-13A2-45F0-8A0B-DA719FC2ED73Q35395985-F7D8C57F-F756-4484-BA29-DB6A53FCCF3AQ35605598-B2078936-66AE-46BE-8541-EAA5888A68AFQ35876263-2DF5A5D1-36AA-471A-A344-F8355F4690D1Q35937458-8983D89D-3EFF-41DA-8CAC-2C1AE260A6BFQ36027890-EBA0F18F-9FF5-4921-ACD7-1DD2D0AB196DQ36352812-76DDFB00-98C2-495B-AF75-B6643B57AC86Q36352823-82002176-296F-41F5-BEDE-0550875A5BE0Q36356730-33D3B237-3E6E-4075-BC0E-92AA2AEFB228Q36363521-5CD1C468-7706-4BA3-B1BE-6A63E8CF9E35Q36366222-3EFCFC4E-05B4-46F5-9F26-091F8CF6EE97Q36466184-03378C43-8F78-40C4-B6AF-95E031744058Q36467183-5E240DF9-64C5-4818-8079-8FE00D27D552Q36613571-45AAEF55-385E-4A49-8C6D-676A36927B9DQ36697378-175AA77C-0052-4A56-A56B-0C7AF04AB348Q36776973-C36024B9-F8A8-4F86-A8CD-5D62D285225BQ36833546-3F294254-9563-48E9-8EF2-F4582DBF6D10Q36843330-1F2199D0-165B-4562-B155-41879638E415Q36926022-D31705D8-862C-44E6-B978-02D8D32E1320Q37480901-510BEDAE-4715-4E59-95AC-9CC7819B0F19Q38339859-F6550200-8B79-4E6E-88EC-AB37CB2A75FEQ39680556-BCB6998F-47A4-40B0-B545-F2FECB854BD7Q40107275-D54F580A-70B7-4683-83C4-01960B145B73Q40561912-736D30C0-26F2-4DEC-9266-C5E503B04D51Q41546161-92746A75-04A0-4ED6-82D6-9D3DB5D40890Q41703408-8C43B0F4-A4DB-426B-96BB-F4A9A30FE11AQ41745124-FE3CC6C4-0F45-4B90-8A0A-941F175FDA6DQ41787837-FED07296-1F5C-4C49-A2C0-963143EA6621Q42832178-27E211DC-E60C-41CC-B70D-D0DB0055354EQ43862702-EFCDB535-11CB-488C-BA7A-DC12495B40A5Q48010302-EC9C584F-EB0E-40A3-B249-6FD1593A2A69
P2860
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh
1985年學術文章
@zh-hant
name
Histocompatibility antigens on murine tumors.
@en
Histocompatibility antigens on murine tumors.
@nl
type
label
Histocompatibility antigens on murine tumors.
@en
Histocompatibility antigens on murine tumors.
@nl
prefLabel
Histocompatibility antigens on murine tumors.
@en
Histocompatibility antigens on murine tumors.
@nl
P2093
P356
P1433
P1476
Histocompatibility antigens on murine tumors.
@en
P2093
P304
P356
10.1126/SCIENCE.2997918
P407
P577
1985-11-01T00:00:00Z